Skip to content
Use caution Drug recall · FDA · Published October 16, 2026

Visine Artificial Tears Recall: Sterility Risk

Preferred Pharmaceuticals recalls specific lots of Visine Artificial Tears due to lack of sterility assurance. Check your bottle's lot number and expiration date.

🇺🇸 FDA recall #D-0158-2027DrugVisine ›
✎ GovInfoNow plain-language explainer

Preferred Pharmaceuticals, Inc. is recalling 480 bottles of Artificial Tears Lubricant Eye Drops sold under the Visine brand. The recall addresses a lack of assurance of sterility in the product. This issue affects specific lots manufactured by Geri-Care in Brooklyn, NY. Read more at govinfonow.com/recall/2249395-preferred-pharmaceuticals-inc-recalls-artificial-tears-lubricant-eye-drops-visine.

Source Summary by GovInfoNow · govinfonow.com/recall/2249395-preferred-pharmaceuticals-inc-recalls-artificial-tears-lubricant-eye-drops-visine · Published November 17, 2026 · Updated November 17, 2026 · FDA enforcement record: FDA #D-0158-2027

Cite this page

“Visine Artificial Tears Recall: Sterility Risk.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2249395-preferred-pharmaceuticals-inc-recalls-artificial-tears-lubricant-eye-drops-visine. Based on FDA recall #D-0158-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0158-2027%22&limit=1).

The FDA announced on Oct. 16, 2026, that Preferred Pharmaceuticals, Inc. is recalling Visine Artificial Tears Lubricant Eye Drops due to a lack of assurance of sterility. Owners should contact the company for a refund.

How to tell if you have it

  • Brand: Visine
  • Product: Artificial Tears Lubricant Eye Drops
  • Pkg Size: 15
  • Mfg: Geri-Care: Brooklyn, NY
  • NDC: 68788-7266-0
  • Lot C2825L, Exp 2/28/2027
  • Lot G1825U, Exp 5/28/2027
  • Lot D0826A, Exp 11/30/2027
  • Lot D1326B, Exp 11/30/2027

The hazard

The product lacks assurance of sterility, which could allow harmful bacteria to grow in the eye drops and cause infection.

Context

GovInfoNow's records show Preferred Pharmaceuticals, Inc. has 33 other recalls on record since Aug. 15, 2018. Other recent recalls of similar products include Lidocaine Ointment (Sept. 28, 2026) and Ondansetron ODT (Nov. 17, 2025). Similar eye drop recalls include Geri-Care Eye Drops (March 25, 2026), Sterile Lubricant Dry Eye Relief Eye Drops (Sept. 11, 2026), Thea Pharma Similasan Eye Drops (April 23, 2026), and Clear Eyes Eye Drops (July 29, 2026).

How to tell if you have this one

Check your bottle for NDC 68788-7266-0 and look for one of these lot numbers: C2825L (Exp 2/28/2027), G1825U (Exp 5/28/2027), D0826A (Exp 11/30/2027), or D1326B (Exp 11/30/2027). The product was manufactured by Geri-Care in Brooklyn, NY.

  • Brand
    Visine
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Bottle

    Verify if your bottle matches the NDC and lot numbers listed in the recall record.

  2. Stop Using Recalled Lots

    If you have a recalled lot, do not use the eye drops due to the sterility risk.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 26 days after the firm started it.

1. Firm started the recall: Oct 16, 202612. FDA classified it Class II: Oct 30, 202623. Published in FDA’s Enforcement Report: Nov 11, 202634. Added to GovInfoNow: Nov 17, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Where was the recalled product sold?

The product was distributed nationwide in the United States.

Similar recalls

Other Visine recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0158-2027 (October 16, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0158-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA